Massive Bio partners to use AI for oncology clinical trials
Massive Bio partners with Perthera.ai to improve cancer clinical trial enrolment through the use of AI technology to connect oncologists and patients with biomarker-based therapy options.
Massive Bio partners with Perthera.ai to improve cancer clinical trial enrolment through the use of AI technology to connect oncologists and patients with biomarker-based therapy options.
US government agrees a deal with Amgen for the supply of Nplate, which is used to treat blood cell injuries due to radiation.
The company, through its subsidiary, PPD, announced that it had created a network that would provide learning materials to those investigators and research sites looking to use decentralized clinical trials (DCTs) for drug development.
Paid for and content provided by Single Use Support
Process flexibility allows CMOs to adapt to the needs of the pharmaceutical industry. It will be inevitable to resort to modular systems in fluid management.